Cargando…

Evaluating the Safety of Maribavir for the Treatment of Cytomegalovirus

PURPOSE OF REVIEW: Cytomegalovirus (CMV) infections are a common complication in solid organ (SOT) and hematopoietic stem cell transplant (HSCT) recipients, leading to increased morbidity and mortality. Currently available treatment options have reduced the burden of infection, but utilization of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandhi, Ronak G, Kotton, Camille N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926008/ https://www.ncbi.nlm.nih.gov/pubmed/35308097 http://dx.doi.org/10.2147/TCRM.S303052

Ejemplares similares

21. Efficacy and Safety of Maribavir as a Rescue Treatment for Investigator Assigned Therapy in Transplant Recipients With Refractory or Resistant Cytomegalovirus Infections in the SOLSTICE Study: Phase 3 Trial Results
por: Pereira, Marcus, et al.
Publicado: (2021)

Maribavir for Cytomegalovirus Treatment in the Real World—Not a Silver Bullet
por: Fung, Monica, et al.
Publicado: (2022)

The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein
por: Shannon-Lowe, Claire D, et al.
Publicado: (2010)

Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient
por: Schubert, Axel, et al.
Publicado: (2013)

Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection
por: Chou, Sunwen, et al.
Publicado: (2020)

Detection of Low Frequency Multi-Drug Resistance and Novel Putative Maribavir Resistance in Immunocompromised Pediatric Patients with Cytomegalovirus
por: Houldcroft, Charlotte J., et al.
Publicado: (2016)

Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus
por: Sun, Kefeng, et al.
Publicado: (2023)

Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection
por: Faure Bardon, Valentine, et al.
Publicado: (2020)

Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavir
por: Gill, Rachel B, et al.
Publicado: (2009)

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial( )
por: Avery, Robin K, et al.
Publicado: (2021)

Synthesis of New Imidazopyridine Nucleoside Derivatives Designed as Maribavir Analogues
por: Papadakis, Georgios, et al.
Publicado: (2020)

Correction to: Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
Publicado: (2023)

Evaluation of the Effect of Maribavir on Cardiac Repolarization in Healthy Participants: Thorough QT/QTc Study
por: Ilic, Katarina, et al.
Publicado: (2020)

Effects of Maribavir on P‐Glycoprotein and CYP2D6 in Healthy Volunteers
por: Song, Ivy H., et al.
Publicado: (2019)

Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
por: Papanicolaou, Genovefa A, et al.
Publicado: (2019)

S294: MARIBAVIR (MBV) VERSUS INVESTIGATOR-ASSIGNED THERAPY FOR REFRACTORY CYTOMEGALOVIRUS (CMV) INFECTION: SUBGROUPS ANALYSES OF PHASE 3 STUDY BY RESISTANCE STATUS KNOWLEDGE REPORTED BY INVESTIGATORS.
por: Duarte, Rafael F, et al.
Publicado: (2023)

Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open‐Label, Single‐Dose, Parallel Group Study
por: Song, Ivy, et al.
Publicado: (2022)

New Insights on CMV Management in Solid Organ Transplant Patients: Prevention, Treatment, and Management of Resistant/Refractory Disease
por: Kotton, Camille Nelson, et al.
Publicado: (2022)

Advances in the treatment of cytomegalovirus
por: Krishna, B A, et al.
Publicado: (2019)

Treatment of congenital cytomegalovirus infection
por: Shim, Gyu Hong
Publicado: (2022)

2719. Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study
por: Nussbaum, Eliezer Zachary, et al.
Publicado: (2023)

Cyclophilin A as a target in the treatment of cytomegalovirus infections
por: A Abdullah, Ashwaq, et al.
Publicado: (2018)

Diagnosis and Treatment of Ulcerative Colitis with Cytomegalovirus Infection: Importance of Controlling Mucosal Inflammation to Prevent Cytomegalovirus Reactivation
por: Nakase, Hiroshi, et al.
Publicado: (2014)

Cytomegalovirus-Specific Immunotherapy for Glioblastoma Treatments
por: Ahn, Jaehyun, et al.
Publicado: (2022)

Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection
por: Ouellette, Christopher P.
Publicado: (2022)

Congenital Cytomegalovirus Infection: Update on Diagnosis and Treatment
por: Chiopris, Giulia, et al.
Publicado: (2020)

Cytomegalovirus Treatment
por: Tan, Ban Hock
Publicado: (2014)

Immunizations in Chronic Kidney Disease and Kidney Transplantation
por: Babu, Tara M., et al.
Publicado: (2021)

A Call for Caution in the Immunocompromised: Coronavirus Disease 2019 Associated With Mortality in a Vaccinated Lung Transplant Recipient
por: Hogan, John I, et al.
Publicado: (2021)

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
por: Patil, A Jayaprakash, et al.
Publicado: (2010)

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
por: Pinninti, Swetha, et al.
Publicado: (2023)

Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021
por: Kotton, Camille N., et al.
Publicado: (2022)

Cytomegalovirus in pregnancy and the neonate
por: Emery, Vincent C., et al.
Publicado: (2017)

Human cytomegalovirus: taking the strain
por: Wilkinson, Gavin W. G., et al.
Publicado: (2015)

Challenges, Recent Advances and Perspectives in the Treatment of Human Cytomegalovirus Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2022)

Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment
por: Marsico, Concetta, et al.
Publicado: (2017)

Infection in Renal Transplant Recipients
por: Kotton, Camille Nelson, et al.
Publicado: (2010)

Cytomegalovirus Anterior Uveitis: Clinical Manifestations, Diagnosis, Treatment, and Immunological Mechanisms
por: Zhang, Jing, et al.
Publicado: (2023)

Tumors and Cytomegalovirus: An Intimate Interplay
por: Herbein, Georges
Publicado: (2022)

An Overview of Cytomegalovirus Infection in Pregnancy
por: Plotogea, Mihaela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_42tkttj3sq4253rlqqpho31gg1